IGI Laboratories Company Profile (NYSE:IG)

About IGI Laboratories

IGI Laboratories logoIGI Laboratories, Inc. is a specialty generic pharmaceutical company. Under its IGI label, the Company sells generic topical pharmaceutical products that are bioequivalent to their brand name counterparts. The Company provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. The Company has two platforms for growth: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. The Company also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics to the prescription treatment of conditions like dermatitis, psoriasis and eczema.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: IG
  • CUSIP:
Key Metrics:
  • Previous Close: $7.68
  • 50 Day Moving Average: $7.71
  • 200 Day Moving Average: $7.24
  • 52-Week Range: $4.75 - $12.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 64.00
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for IGI Laboratories (NYSE:IG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for IGI Laboratories (NYSE:IG)
Show:
DateFirmActionRatingPrice TargetDetails
10/23/2015Roth CapitalReiterated RatingBuyView Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
7/20/2015Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformView Rating Details
4/29/2015Avondale PartnersDowngradeOutperform -> Market PerformView Rating Details
4/7/2015Deutsche Bank AGInitiated CoverageBuy$10.00View Rating Details
3/23/2015Craig HallumReiterated RatingBuy$14.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for IGI Laboratories (NYSE:IG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/21/2015        
10/22/2015Q315($0.05)($0.02)$9.36 million$11.60 millionViewListenView Earnings Details
7/23/2015Q2($0.08)($0.04)$7.63 million$8.90 millionViewListenView Earnings Details
3/2/2015Q414$0.06$0.09$11.88 million$13.70 millionViewN/AView Earnings Details
7/24/2014($0.01)ViewN/AView Earnings Details
2/27/2014Q4$0.01($0.01)ViewListenView Earnings Details
11/13/2012Q312($0.04)$2.11 million$1.98 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IGI Laboratories (NYSE:IG)
Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $0.12 EPS

Dividends

Dividend History for IGI Laboratories (NYSE:IG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for IGI Laboratories (NYSE:IG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2015Jason Grenfell-GardnerCEOSell84,048$7.94$667,341.12View SEC Filing  
4/30/2015James C GaleDirectorBuy30,000$5.04$151,200.00View SEC Filing  
3/5/2015Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$9.95$19,900,000.00View SEC Filing  
9/2/2014Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$6.45$12,900,000.00View SEC Filing  
8/27/2014Sciences Opportunities Fu LifeMajor ShareholderSell3,000,000$6.20$18,600,000.00View SEC Filing  
8/22/2014James C GaleDirectorBuy5,000$5.90$29,500.00View SEC Filing  
8/4/2014Jason Grenfell-GardnerCEOSell66,828$5.85$390,943.80View SEC Filing  
6/9/2014Joyce EronyDirectorSell17,500$5.48$95,900.00View SEC Filing  
8/6/2013Michael B HemricDirectorBuy50,000$1.48$74,000.00View SEC Filing  
5/24/2013Jason Grenfell-GardnerCEOBuy3,500$1.55$5,425.00View SEC Filing  
3/13/2013James C GaleDirectorBuy10,000$1.33$13,300.00View SEC Filing  
3/12/2013Michael B HemricDirectorBuy20,637$1.19$24,558.03View SEC Filing  
8/14/2012Jason Grenfell-GardnerCEOBuy10,000$1.15$11,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for IGI Laboratories (NYSE:IG)
DateHeadline
News IconA2 Acquisition Corp. Announces Proposed Qualifying Transaction With Medicenna Therapeutics Inc. - Satellite PR News (press release) (NYSE:IG)
www.satprnews.com - February 6 at 5:55 PM
marketwired.com logoA2 Acquisition Corp. Announces Proposed Qualifying Transaction With Medicenna Therapeutics Inc. (NYSE:IG)
www.marketwired.com - February 6 at 10:38 AM
News IconJean Lynch is recognized by Continental Who's Who (NYSE:IG)
www.bio-medicine.org - January 30 at 6:35 PM
News IconInvestigation for Investors in shares of Teligent Inc (NASDAQ:TLGT) announced (NYSE:IG)
www.groundreport.com - January 25 at 7:14 PM
News IconNASDAQ:TLGT Investor Alert: Investigation over Possible Wrongdoing at Teligent Inc - Digital Journal (NYSE:IG)
www.digitaljournal.com - January 19 at 7:37 PM
News IconReviewing Individual Broker Targets Of IGI Laboratories, Inc. (IG) - NewsDen (NYSE:IG)
newsden.net - January 19 at 4:25 AM
News IconMedicenna Announces Additions to the Board of Directors - The Province (NYSE:IG)
www.theprovince.com - January 17 at 6:23 PM
News IconIGI Laboratories, Inc. (IG) Under Analyst Spotlight - UK Market News (NYSE:IG)
www.ukmarketnews.co.uk - January 6 at 11:34 PM
openpr.com logoPharmaceutical outsourcing Market Expected to Be Biggest Emerging Market by 2024 (NYSE:IG)
www.openpr.com - December 29 at 3:50 AM
publicnow.com logoItalgas: 2017 financial calendar (NYSE:IG)
www.publicnow.com - December 21 at 12:22 AM
bizjournals.com logo4 reasons why a Bucks County pharma firm attracted a $19.5M investment - Philadelphia Business Journal (NYSE:IG)
www.bizjournals.com - December 8 at 11:29 PM
News IconIGI Laboratories, Inc. (IG) Valuation According To Analysts - UK Market News (NYSE:IG)
www.ukmarketnews.co.uk - November 30 at 9:35 AM
publicnow.com logoItalgas finalises its First Euro Medium Term Notes Programme (NYSE:IG)
www.publicnow.com - November 21 at 10:42 AM
News IconLatest Analyst Consensus For IGI Laboratories, Inc. (IG) - UK Market ... - UK Market News (NYSE:IG)
www.ukmarketnews.co.uk - November 15 at 9:06 AM
News IconCurrent Price Targets For IGI Laboratories, Inc. (IG) - NewsDen (NYSE:IG)
newsden.net - November 13 at 9:41 AM
News IconUpgrades And Downgrades For IGI Laboratories, Inc. (IG) - NewsDen (NYSE:IG)
newsden.net - November 9 at 5:15 PM
News IconIGI Laboratories, Inc. (IG) Updated Broker Ratings - NewsDen (NYSE:IG)
newsden.net - November 5 at 6:49 AM
openpr.com logoPharmaceutical outsourcing Market Explores New Growth Opportunities By 2016 - 2024 (NYSE:IG)
www.openpr.com - October 20 at 11:09 AM
News IconGlobal Pharmaceutical Outsourcing Market Will Witness Dramatic Growth by 2024 (NYSE:IG)
www.medgadget.com - October 14 at 5:29 PM
News IconPharmaceutical outsourcing Market Expecting Worldwide Growth by 2024 – Persistence Market Research - Medgadget (blog) (NYSE:IG)
www.medgadget.com - October 14 at 8:45 AM
News IconAnalysts' Upgrades for October, 12th (AAPL, GOOGL, HAL, JE, NMBL, TESO, TISI, TLGT, TPVG, TSQ) - Evergreen Investor (NYSE:IG)
www.evergreeninvestor.com - October 12 at 10:41 AM
News IconRecently Changed Price Targets On IGI Laboratories, Inc. (IG) - NewsDen (NYSE:IG)
newsden.net - September 29 at 10:40 AM
sbwire.com logoPharmaceutical Outsourcing Market: Global Industry Analysis and Forecast 2016-2024 (NYSE:IG)
www.sbwire.com - September 14 at 5:41 PM
News IconImprimis Pharmaceuticals Expands its Leadership Team in Operations, Quality, Manufacturing, and Client Relations (NYSE:IG)
eyewiretoday.com - August 15 at 5:52 PM
istreetwire.com logoStocks Buzz: Agilent Technologies (A), Waddell & Reed (WDR), Parker Hannifin (NYSE:PH) - iStreetWire (NYSE:IG)
istreetwire.com - July 5 at 5:28 PM
News IconBuena pharmaceutical firm tripling plant, doubling jobs - Press of Atlantic City (NYSE:IG)
www.pressofatlanticcity.com - June 27 at 5:33 PM
News IconTeligent Inc Just Recorded A Sigfniciant Increase - Stock Caller (NYSE:IG)
www.stockcaller.com - April 17 at 7:15 AM
News IconTeligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 2.54% After Short Covering - RiversideGazette.com (NYSE:IG)
www.riversidegazette.com - April 5 at 12:59 PM
News IconDiamond Detectives - Rapaport (NYSE:IG)
www.diamonds.net - April 2 at 11:50 AM
prnewswire.com logoTeligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of Directors - PR Newswire (press release) (NYSE:IG)
www.prnewswire.com - March 31 at 1:54 PM
clintongazette.com logoTeligent Incorporated (NASDAQ:TLGT) Short Interest Decreased By 6.19% - Clinton Financial (NYSE:IG)
www.clintongazette.com - March 25 at 1:43 PM
prnewswire.com logoTeligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) - PR Newswire (press release) (NYSE:IG)
www.prnewswire.com - March 21 at 2:10 PM
News IconDeutsche Bank Maintains Teligent Inc to Hold with Price Target $8.00 - Street Edition (NYSE:IG)
www.streetedition.net - March 20 at 1:27 PM
biz.yahoo.com logoTELIGENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NYSE:IG)
biz.yahoo.com - December 4 at 6:05 AM
finance.yahoo.com logoTELIGENT, INC. Financials (NYSE:IG)
finance.yahoo.com - October 29 at 1:04 PM

Social

What is IGI Laboratories' stock symbol?

IGI Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "IG."

When will IGI Laboratories announce their earnings?

IGI Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October, 21st 2015.

How do I buy IGI Laboratories stock?

Shares of IGI Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of IGI Laboratories stock cost?

One share of IGI Laboratories stock can currently be purchased for approximately $7.68.

IGI Laboratories (NYSE:IG) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for IGI Laboratories (NYSE:IG)

Earnings History Chart

Earnings by Quarter for IGI Laboratories (NYSE:IG)

Dividend History Chart

Dividend Payments by Quarter for IGI Laboratories (NYSE:IG)

Last Updated on 2/24/2017 by MarketBeat.com Staff